Clinical trials
Completed Carcinoma, Non-Small-Cell Lung trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,525 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 43 |
| 2001 | 37 |
| 2002 | 50 |
| 2003 | 63 |
| 2004 | 77 |
| 2005 | 74 |
| 2006 | 86 |
| 2007 | 72 |
| 2008 | 71 |
| 2009 | 73 |
| 2010 | 47 |
| 2011 | 60 |
| 2012 | 52 |
| 2013 | 68 |
| 2014 | 52 |
| 2015 | 77 |
| 2016 | 76 |
| 2017 | 76 |
| 2018 | 69 |
| 2019 | 50 |
| 2020 | 45 |
| 2021 | 46 |
| 2022 | 23 |
| 2023 | 13 |
| 2024 | 11 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,525 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 93 |
| Eli Lilly and Company | 63 |
| M.D. Anderson Cancer Center | 49 |
| Alliance for Clinical Trials in Oncology | 47 |
| Memorial Sloan Kettering Cancer Center | 43 |
| Pfizer | 43 |
| AstraZeneca | 30 |
| Novartis Pharmaceuticals | 29 |
| Bristol-Myers Squibb | 26 |
| Roswell Park Cancer Institute | 22 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 1,525 |
| Lung Neoplasms | 600 |
| Neoplasms | 155 |
| Breast Neoplasms | 147 |
| Small Cell Lung Carcinoma | 140 |
| Colorectal Neoplasms | 122 |
| Melanoma | 114 |
| Pancreatic Neoplasms | 108 |
| Adenocarcinoma of Lung | 105 |
| Ovarian Neoplasms | 105 |
Trials
Showing 1 to 25 of 1,525. Each trial links to its page on Pharma Observatory.
1,425 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.